# Ilioinguinal Nerve Block in Transcatheter Aortic Valve Implantation

> **NCT05220813** · PHASE4 · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 88 (estimated)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** Bupivacain

## Key facts

- **NCT ID:** NCT05220813
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-11
- **Primary completion:** 2022-05
- **Final completion:** 2022-05
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2022-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05220813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05220813, "Ilioinguinal Nerve Block in Transcatheter Aortic Valve Implantation". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05220813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*